The gov't overhaul of the U.S. health care system should drive more business to drugstore chain CVS Caremark (CVS), the company said, as it raised its 2013 EPS outlook to $3.84-$3.98, above estimates of $3.82. CVS also lifted its quarterly dividend 38% to 22.5 cents a share. It expects Q1 sales to fall 2.5%-4% vs. last year due to a shift to cheaper generic drugs. CVS climbed 2% to 48.50.
- Investment & Company Information
- CVS Caremark